Novel 4-Anilinopyrimidine-N-Acylhydrazone derivatives as dual EGFRWT/VEGFR-2 tyrosine kinase inhibitors against non-small cell lung Cancer: Design, synthesis, biological evaluation, and computational studies

Bioorganic Chemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles